Skip to main content
Medical information Clinical review pending

Cardiology

Lupus Anticoagulant By APTT PTTLA Test

Detects lupus anticoagulants, antibodies linked to an increased risk of blood clots (thromboembolic disorders). This test helps diagnose and manage conditions like deep vein thrombosis and pulmonary embolism.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample collected in a specific tube containing a citrate anticoagulant. Confirm with the laboratory before booking.
Results
Confirm with the laboratory before booking.
Preparation
Overnight fasting is preferred. Inform your doctor if you are taking any medications, especially blood thinners (anticoagulants like Heparin or Warfarin), as they may need to be stopped temporarily before the test. Discuss this with your physician first. Complete the required requisition form.
Test priceKSh 1,544

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Lupus Anticoagulant By APTT PTTLA Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓History of unexplained blood clots (thrombosis).
  • ✓Recurrent miscarriages.
  • ✓Diagnosis of autoimmune disorders like lupus.
  • ✓Symptoms suggestive of clotting issues (e.g., limb swelling, pain).
  • ✓Monitoring patients with known antiphospholipid syndrome.
  • ✓Evaluation before certain surgical procedures.
02

In plain language

What this test helps you understand

This test helps identify individuals at risk for thromboembolic events due to the presence of lupus anticoagulants. It aids in the diagnosis of antiphospholipid syndrome and supports clinical decision-making regarding anticoagulation therapy.
The Lupus Anticoagulant By APTT PTTLA Test is a diagnostic tool used to identify lupus anticoagulants in the blood. These are antibodies that can paradoxically increase the risk of blood clotting, leading to conditions like deep vein thrombosis (DVT) or pulmonary embolism (PE). This test is important for understanding clotting risks, especially in individuals with certain medical histories or symptoms.

This test measures how long it takes for your blood to clot using the Activated Partial Thromboplastin Time (APTT) method. It helps identify abnormalities in the clotting process that might be caused by lupus anticoagulants.

Understanding the presence of these antibodies is crucial for managing patients at risk of thromboembolic events and for guiding appropriate treatment strategies.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationOvernight fasting is preferred. Inform your doctor if you are taking any medications, especially blood thinners (anticoagulants like Heparin or Warfarin), as they may need to be stopped temporarily before the test. Discuss this with your physician first. Complete the required requisition form.
SampleBlood sample collected in a specific tube containing a citrate anticoagulant. Confirm with the laboratory before booking.
MethodologyThe test uses the Activated Partial Thromboplastin Time (APTT) method to assess blood clotting time in the presence of specific reagents designed to detect lupus anticoagulants.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test may be affected by certain medications and medical conditions. False positive or false negative results can occur. Results must be interpreted by a qualified healthcare professional in conjunction with clinical findings.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

A lupus anticoagulant is an antibody found in the blood that paradoxically increases the risk of blood clots, rather than preventing them. It's associated with certain autoimmune conditions.
This test helps identify individuals at higher risk of developing serious blood clots like deep vein thrombosis or pulmonary embolism, allowing for appropriate management and prevention strategies.
Overnight fasting is preferred. Please confirm specific preparation instructions with the laboratory or your doctor.
If you are taking blood thinners (anticoagulants), you must inform your doctor. You may need to temporarily stop them before the test, but only under your doctor's guidance.
A healthcare professional will interpret the results based on your medical history and other tests. A positive result indicates the presence of lupus anticoagulants and requires further discussion with your doctor.
We have branches across Kenya and offer home sample collection. Please contact us at +254711564616 to book your test or inquire about locations.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp